Different Effects of Three Selected Lactobacillus Strains in Dextran Sulfate Sodium-Induced Colitis in BALB/c Mice

Aim To analyze the changes of different Lactobacillus species in ulcerative colitis patients and to further assess the therapeutic effects of selected Lactobacillus strains on dextran sulfate sodium (DSS)-induced experimental colitis in BALB/c mice. Methods Forty-five active ulcerative colitis (UC) patients and 45 population-based healthy controls were enrolled. Polymerase chain reaction (PCR) amplification and real-time PCR were performed for qualitative and quantitative analyses, respectively, of the Lactobacillus species in UC patients. Three Lactobacillus strains from three species were selected to assess the therapeutic effects on experimental colitis. Sixty 8-week-old BALB/c mice were divided into six groups. The five groups that had received DSS were administered normal saline, mesalazine, L. fermentum CCTCC M206110 strain, L. crispatus CCTCC M206119 strain, or L. plantarum NCIMB8826 strain. We assessed the severity of colitis based on disease activity index (DAI), body weight loss, colon length, and histologic damage. Results The detection rate of four of the 11 Lactobacillus species decreased significantly (P < 0.05), and the detection rate of two of the 11 Lactobacillus species increased significantly (P < 0.05) in UC patients. Relative quantitative analysis revealed that eight Lactobacillus species declined significantly in UC patients (P < 0.05), while three Lactobacillus species increased significantly (P < 0.05). The CCTCC M206110 treatment group had less weight loss and colon length shortening, lower DAI scores, and lower histologic scores (P < 0.05), while the CCTCC M206119 treatment group had greater weight loss and colon length shortening, higher histologic scores, and more severe inflammatory infiltration (P < 0.05). NCIMB8826 improved weight loss and colon length shortening (P < 0.05) with no significant influence on DAI and histologic damage in the colitis model. Conclusions Administration of an L. crispatus CCTCC M206119 supplement aggravated DSS-induced colitis. L. fermentum CCTCC M206110 proved to be effective at attenuating DSS-induced colitis. The potential probiotic effect of L. plantarum NCIMB8826 on UC has yet to be assessed.

[1]  J. Fichna,et al.  Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.

[2]  M. A. Rosillo,et al.  Effects of dietary virgin olive oil polyphenols: hydroxytyrosyl acetate and 3, 4-dihydroxyphenylglycol on DSS-induced acute colitis in mice. , 2015, The Journal of nutritional biochemistry.

[3]  A. Gasbarrini,et al.  The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy. , 2015, Pharmacology & therapeutics.

[4]  C. S. Satish Kumar,et al.  Protective effect of Lactobacillus plantarum 21, a probiotic on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats. , 2015, International immunopharmacology.

[5]  H. Sokol,et al.  Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model , 2015, BMC Microbiology.

[6]  A. Peña,et al.  Intestinal Microbiota as Modulators of the Immune System , 2015, Journal of immunology research.

[7]  Dong-Hyun Kim,et al.  Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages. , 2014, International immunopharmacology.

[8]  F. Zuo,et al.  Combination of heterogeneous catalase and superoxide dismutase protects Bifidobacterium longum strain NCC2705 from oxidative stress , 2014, Applied Microbiology and Biotechnology.

[9]  H. Arakawa,et al.  Long-Term Alteration of Intestinal Microbiota in Patients with Ulcerative Colitis by Antibiotic Combination Therapy , 2014, PloS one.

[10]  F. Lu,et al.  Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis. , 2013, World journal of gastroenterology.

[11]  M. Hattori,et al.  Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota , 2013, Nature.

[12]  S. Qiao,et al.  Expression of catalase in Lactobacillus fermentum and evaluation of its anti-oxidative properties in a dextran sodium sulfate induced mouse colitis model , 2013, World Journal of Microbiology and Biotechnology.

[13]  Jung Ok Shim,et al.  Gut Microbiota in Inflammatory Bowel Disease , 2013, Pediatric gastroenterology, hepatology & nutrition.

[14]  C. O'Morain,et al.  Geographical variability and environmental risk factors in inflammatory bowel disease , 2013, Gut.

[15]  M. F. Jahromi,et al.  Correlation Coefficients Between Different Methods of Expressing Bacterial Quantification Using Real Time PCR , 2012, International journal of molecular sciences.

[16]  L. Stronati,et al.  Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis , 2012, Alimentary pharmacology & therapeutics.

[17]  Tzu-Hao Cheng,et al.  Oral administration of Lactobacillus plantarum K68 ameliorates DSS-induced ulcerative colitis in BALB/c mice via the anti-inflammatory and immunomodulatory activities. , 2011, International immunopharmacology.

[18]  T. Ulinski,et al.  Pediatric idiopathic nephrotic syndrome: treatment strategies in steroid dependent and steroid resistant forms. , 2010, Current medicinal chemistry.

[19]  J. Gong,et al.  Identification of changes in the composition of ileal bacterial microbiota of broiler chickens infected with Clostridium perfringens. , 2010, Veterinary microbiology.

[20]  A. Sood,et al.  The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  R. Baldassano,et al.  Effect of a Probiotic Preparation (VSL#3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis , 2009, The American Journal of Gastroenterology.

[22]  R Balfour Sartor,et al.  Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.

[23]  M. Geier,et al.  Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats. , 2007, International journal of food microbiology.

[24]  A. Gasbarrini,et al.  Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis , 2006, Alimentary pharmacology & therapeutics.

[25]  S. Hanauer,et al.  Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities , 2006, Inflammatory bowel diseases.

[26]  J. H. I. Huis in't Veld,et al.  Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice. , 2005, International journal of food microbiology.

[27]  L. Morelli,et al.  Beneficial effect of auto-aggregating Lactobacillus crispatus on experimentally induced colitis in mice. , 2005, FEMS immunology and medical microbiology.

[28]  R Balfour Sartor,et al.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.

[29]  J. Hampe,et al.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease , 2004, Gut.

[30]  R. Sartor,et al.  Lactobacillus plantarum 299V in the Treatment and Prevention of Spontaneous Colitis in Interleukin-10-Deficient Mice , 2002, Inflammatory bowel diseases.

[31]  H. Cooper,et al.  Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin , 1993, Digestive Diseases and Sciences.

[32]  H. Cooper,et al.  Clinicopathologic study of dextran sulfate sodium experimental murine colitis. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[33]  Subrata Ghosh,et al.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.

[34]  M. Picco.  Effect of a Probiotic Preparation (VSL#3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis , 2009 .

[35]  P. Rossmann,et al.  Oral administration of probiotic bacteria (E. coli nissle,E. coli O83,Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice , 2008, Folia Microbiologica.

[36]  P. Jansen,et al.  Blockade of NF-kappaB activation and donation of nitric oxide: new treatment options in inflammatory bowel disease? , 2002, Scandinavian journal of gastroenterology. Supplement.